School of Medicine


Showing 11-20 of 54 Results

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Kate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.

  • Nancy A. Haug

    Nancy A. Haug

    Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Nancy A. Haug, Ph.D. is Adjunct Clinical Associate Professor and Addiction Medicine Fellowship Program Faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and supervises a supplemental practicum for doctoral students who are co-facilitating group therapy.

    Dr. Haug is also Professor and Associate Chair of the Department of Psychology at Palo Alto University where she teaches, advises and supervises graduate students, and leads the Harm Reduction and Addiction Treatment Research Laboratory. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program.

    Dr. Haug was recently funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. She is active in the Society of Addiction Psychology (American Psychological Association, Division 50) and chairs the Outreach and Dissemination committee. Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. Throughout her academic career, Dr. Haug has focused on behavioral and psychosocial interventions for treating addiction, and currently has projects studying mindfulness group treatment for addiction, cannabis vaping practices and online interventions for alcohol harm reduction. Dr. Haug has been licensed in CA since 2004 and has a private practice which informs her research and teaching.

  • Chris Hayward

    Chris Hayward

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

    Current Research and Scholarly Interests Dr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.

  • Alesha Heath

    Alesha Heath

    Postdoctoral Research Fellow, Psychiatry

    Bio Dr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.

    Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease.

  • Claire Hebenstreit

    Claire Hebenstreit

    Clinical Assistant Professor (Affiliated) [Vapahcs], Psych/General Psychiatry and Psychology (Adult)

    Bio Dr. Hebenstreit received her PhD in clinical psychology from the University of Denver and completed predoctoral internship at the VA Palo Alto Health Care System. From 2013-2016 she was a VA Advanced Fellow in Women’s Health Research at the San Francisco VA Medical Center and a research affiliate of the University of California San Francisco. She is an attending psychologist in Inpatient Mental Health at VA Palo Alto, where she provides clinical training and supervision through the Psychology Service as well as the Stanford Psychiatry Residency program. Her research areas have included interpersonal and intimate partner violence against women, emerging health care needs of women veterans within the VA system, and workplace violence prevention. Her clinical interests include severe mental illness and clinical care in inpatient psychiatry.

Latest information on COVID-19